FindTrial
Sign In

The study or the treatment for symptoms caused by cancer or cancer treatments

The Study of the Treatment with Human Mesenchymal Stem Cell Conditioned Medium for Cancerous Cachexia and the Various Symptoms Caused by Cancer Treatments

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1051240096
Enrollment
Unknown
Registered
2024-07-22
Start date
2024-02-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Cancerous cachexia, symptoms caused by cancer therapies cachexia

Interventions

None listed

Sponsors

Hori Atsushi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Individuals who want to alleviate cancerous cachexia or symptoms caused by cancer therapies. 2. Individuals who are determided by the doctor to be appropriate for receive the treatment with the conditioned medium. Patients meeting the following criteria are eligible: 1. Individuals aged 18 years or older. 2. Individuals with normal capacity to consent. 3. Individuals who have been provided with the informed consent document for this treatment, have received sufficient explanation, and are capable of providing written consent freely and voluntarily. 4. Individuals for whom the attending physician has recognized the necessity of treatment.

Exclusion criteria

Exclusion criteria: Individuals meeting any of the following conditions will be excluded: 1. Users of narcotics or stimulants. 2. Individuals deemed inappropriate by the attending physician.

Design outcomes

Primary

MeasureTime frame
Medical records, Period of cancer, Medical examinations—

Contacts

Public ContactMasahiro To

IGT Clinic

toriim@igtc.jp+81-72-463-3811

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026